Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples

por Fleseriu, Maria, Biller, Beverly M. K.
Publicado 2022

Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation

por Bidlingmaier, Martin, Biller, Beverly M.K., Clemmons, David, Jørgensen, Jens Otto L., Nishioka, Hiroshi, Takahashi, Yutaka
Publicado 2023

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant

por Strasburger, Christian J, Mattsson, Anders, Wilton, Patrick, Aydin, Ferah, Hey-Hadavi, Judith, Biller, Beverly M K
Publicado 2018

COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess

por Pivonello, Rosario, Ferrigno, Rosario, Isidori, Andrea M, Biller, Beverly M K, Grossman, Ashley B, Colao, Annamaria
Publicado 2020

Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency

por Kildemoes, Rasmus Juul, Hollensen, Christian, Biller, Beverly M K, Johannsson, Gudmundur, Takahashi, Yutaka, Rasmussen, Michael Højby
Publicado 2022

Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation

por Bidlingmaier, Martin, Biller, Beverly M.K., Clemmons, David, Jørgensen, Jens Otto L., Nishioka, Hiroshi, Takahashi, Yutaka
Publicado 2022

Health Care Burden in Patients With Adrenal Insufficiency

por Gunnarsson, Candace, Ryan, Michael P., Marelli, Claudio, Baker, Erin R., Stewart, Paul M., Johannsson, Gudmundur, Biller, Beverly M. K.
Publicado 2017

Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study

por Findling, James W., Fleseriu, Maria, Newell-Price, John, Petersenn, Stephan, Pivonello, Rosario, Kandra, Albert, Pedroncelli, Alberto M., Biller, Beverly M. K.
Publicado 2016

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enab...

por Biller, Beverly M. K., Höybye, Charlotte, Carroll, Paul, Gordon, Murray B., Birkegård, Anna Camilla, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias M.
Publicado 2021

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

por Biller, Beverly M K, Höybye, Charlotte, Ferran, Jean-Marc, Kelepouris, Nicky, Nedjatian, Navid, Olsen, Anne Helene, Weber, Matthias M, Gordon, Murray B
Publicado 2023

Long-Term Control of Urinary Free Cortisol With Osilodrostat in Patients With Cushing’s Disease: Final Results From the LINC 2 Study

por Fleseriu, Maria, Biller, Beverly M K, Bertherat, Jerome, Young, Jacques, Arnaldi, Giorgio, O’Connell, Paul, Izquierdo, Miguel, Pedroncelli, Alberto M, Pivonello, Rosario
Publicado 2021

PMON163 Effect of Osilodrostat on Androgens and Adrenal Hormones in Patients With Cushing's Disease: Long-Term Findings From the Phase III, Prospective LINC 3 Study

por Fleseriu, Maria, Biller, Beverly M K, Shimatsu, Akira, Newell-Price, John, Tabarin, Antoine, Vila, Greisa, Piacentini, Andrea, Pedroncelli, Alberto M, Pivonello, Rosario
Publicado 2022

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

por Höybye, Charlotte, Biller, Beverly M K, Ferran, Jean-Marc, Gordon, Murray B, Kelepouris, Nicky, Nedjatian, Navid, Olsen, Anne H, Weber, Matthias M
Publicado 2022

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial

por Johannsson, Gudmundur, Gordon, Murray B, Højby Rasmussen, Michael, Håkonsson, Ida Holme, Karges, Wolfram, Sværke, Claus, Tahara, Shigeyuki, Takano, Koji, Biller, Beverly M K
Publicado 2020

PMON160 Improvements in Clinical Signs of Hypercortisolism and Quality of Life According to Urinary and Late-Night Salivary Cortisol Levels in Patients with Cushing's Disease Treat...

por Biller, Beverly M K, Fleseriu, Maria, Pivonello, Rosario, Feelders, Richard A, Lacroix, Andre, Auchus, Richard J, Piacentini, Andrea, Pedroncelli, Alberto M, Newell-Price, John
Publicado 2022

Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)

por Fleseriu, Maria, Biller, Beverly M. K., Bertherat, Jérôme, Young, Jacques, Hatipoglu, Betul, Arnaldi, Giorgio, O’Connell, Paul, Izquierdo, Miguel, Pedroncelli, Alberto M., Pivonello, Rosario
Publicado 2022

Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency

por Takahashi, Yutaka, Biller, Beverly M. K., Fukuoka, Hidenori, Ho, Ken K. Y., Rasmussen, Michael Højby, Nedjatian, Navid, Sværke, Claus, Yuen, Kevin C. J., Johannsson, Gudmundur
Publicado 2022

THU038 Osilodrostat Dosing In Cushing’s Disease: A Pooled Analysis Of The LINC Program

por Newell-Price, John, Pivonello, Rosario, Lacroix, André, Biller, Beverly M K, Feelders, Richard, Gadelha, Mônica, Bertherat, Jérôme, Belaya, Zhanna, Piacentini, Andrea, Pedroncelli, Alberto M, Fleseriu, Maria
Publicado 2023

THU041 Clinical Improvements In Patients With Cushing’s Disease Treated With Osilodrostat According To Urinary And Late-night Salivary Cortisol Levels: Pooled Analysis From LINC 3...

por Biller, Beverly M K, Fleseriu, Maria, Pivonello, Rosario, Feelders, Richard, Gadelha, Mônica, Lacroix, André, Witek, Przemysław, Heaney, Anthony P, Piacentini, Andrea, Pedroncelli, Alberto M, Newell-Price, John
Publicado 2023

Hypertension in Acromegaly in Relationship to Biochemical Control and Mortality: Global ACROSTUDY Outcomes

por Vila, Greisa, Luger, Anton, van der Lely, Aart Jan, Neggers, Sebastian J. C. M. M., Webb, Susan M., Biller, Beverly M. K., Valluri, Srinivas, Hey-Hadavi, Judith
Publicado 2020